Embecta (NASDAQ:EMBC) Trading 4.4% Higher - Still a Buy?

Embecta Corp. (NASDAQ:EMBC - Get Free Report)'s stock price was up 4.4% on Monday . The stock traded as high as $12.72 and last traded at $12.82. Approximately 307,456 shares changed hands during mid-day trading, a decline of 30% from the average daily volume of 439,901 shares. The stock had previously closed at $12.28.

Embecta Stock Down 3.0 %

The stock has a market cap of $697.61 million, a P/E ratio of 12.00, a PEG ratio of 0.78 and a beta of 1.27. The stock has a fifty day simple moving average of $14.76 and a 200-day simple moving average of $16.18.

Embecta (NASDAQ:EMBC - Get Free Report) last released its quarterly earnings data on Thursday, February 6th. The company reported $0.65 earnings per share for the quarter, topping the consensus estimate of $0.45 by $0.20. Embecta had a net margin of 5.25% and a negative return on equity of 19.22%. Sell-side analysts anticipate that Embecta Corp. will post 2.85 earnings per share for the current year.

Embecta Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Friday, March 14th. Investors of record on Friday, February 28th were paid a dividend of $0.15 per share. This represents a $0.60 annualized dividend and a yield of 5.00%. The ex-dividend date of this dividend was Friday, February 28th. Embecta's payout ratio is presently 60.00%.

Insiders Place Their Bets

In other news, Director Milton Mayo Morris sold 3,100 shares of Embecta stock in a transaction dated Thursday, February 13th. The stock was sold at an average price of $16.38, for a total transaction of $50,778.00. Following the transaction, the director now owns 36,133 shares in the company, valued at $591,858.54. The trade was a 7.90 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Corporate insiders own 0.42% of the company's stock.

Remove Ads

Institutional Trading of Embecta

Several hedge funds have recently bought and sold shares of EMBC. Smartleaf Asset Management LLC increased its position in shares of Embecta by 175.1% during the fourth quarter. Smartleaf Asset Management LLC now owns 1,216 shares of the company's stock worth $25,000 after acquiring an additional 774 shares in the last quarter. Sterling Capital Management LLC boosted its stake in Embecta by 796.3% in the 4th quarter. Sterling Capital Management LLC now owns 1,685 shares of the company's stock worth $35,000 after purchasing an additional 1,497 shares during the period. Quarry LP bought a new position in Embecta during the 3rd quarter worth about $30,000. Ameriflex Group Inc. acquired a new stake in shares of Embecta in the 4th quarter valued at about $53,000. Finally, Siemens Fonds Invest GmbH bought a new stake in shares of Embecta in the fourth quarter valued at about $77,000. 93.83% of the stock is currently owned by institutional investors and hedge funds.

About Embecta

Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes.